Nothing Ruled Out IMHOAs they say, a bird in hand is worth two in the bush.
Don now has a bird in his hand.
QUESTION: Is there anything to prevent a second, larger bird from jumping into Don's net before the close date of the transaction in China?
I don't think we have heard anything that would rule that possibility out.
Seems that the time may be ripe for additional (competing) offers from other pharma.
Don is suddenly in a very strong negotiating position:
1. China deal in hand
2. Emerald Logic information on file
3. Potential Nasdaq listing out there
4. Improved stock price of late
The next several months might be more interesting that we anticipate....
IMHO. DYODD. GLTA.